Neochromosome Overview
- Year Founded
-
2015
- Status
-
Acquired/Merged
- Employees
-
42
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
1
Neochromosome General Information
Description
Developer of genome-scale synthetic biology technology designed to enable biological engineering. The company's platform provides automated deoxyribonucleic acid synthesis, de novo chromosome engineering, and cellular delivery capabilities, enabling researchers and life science organizations to develop novel therapeutics, sustainable products, and advanced biological research with precision at the genomic scale.
Contact Information
Website
www.neochromosome.com(Operating Subsidiary)
Corporate Office
- 45-18 Court Square West, Queens
- New York, NY 11101
- United States
Corporate Office
- 45-18 Court Square West, Queens
- New York, NY 11101
- United States
Neochromosome Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Accelerator/Incubator | 01-Jan-2025 | Completed | Generating Revenue | |||
| 7. Merger/Acquisition | 01-Mar-2021 | Completed | Generating Revenue | |||
| 6. Grant | 02-May-2020 | Completed | Generating Revenue | |||
| 5. Grant | 01-Jan-2020 | Completed | Generating Revenue | |||
| 4. Accelerator/Incubator | 18-Oct-2019 | Completed | Generating Revenue | |||
| 3. Grant | 14-May-2018 | Completed | Generating Revenue | |||
| 2. Grant | 01-May-2018 | $150K | $100K | Completed | Generating Revenue | |
| 1. Accelerator/Incubator | 13-Jun-2017 | $100K | $100K | Completed | Generating Revenue |
Neochromosome Patents
Neochromosome Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4208565-A1 | Methods and systems for nucleic acid synthesis | Inactive | 01-Sep-2020 | ||
| EP-4208565-A4 | Methods and systems for nucleic acid synthesis | Inactive | 01-Sep-2020 | ||
| US-20230053916-A1 | Methods and systems for nucleic acid synthesis | Inactive | 01-Sep-2020 | ||
| WO-2022051369-A1 | Methods and systems for nucleic acid synthesis | Inactive | 01-Sep-2020 | ||
| US-10865417-B2 | Yeast synthetic biology platform for identifying shikimate pathway enzyme inhibitors | Active | 06-Apr-2018 | C12N15/81 |
Neochromosome Signals
Neochromosome Former Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Alexandria LaunchLabs | Accelerator/Incubator | Minority | ||
| Endless Frontier Labs | Accelerator/Incubator | Minority | ||
| National Institute Of Allergy and Infectious Diseases | Government | |||
| National Institutes of Health | Government |
Neochromosome FAQs
-
When was Neochromosome founded?
Neochromosome was founded in 2015.
-
Where is Neochromosome headquartered?
Neochromosome is headquartered in New York, NY.
-
What is the size of Neochromosome?
Neochromosome has 42 total employees.
-
What industry is Neochromosome in?
Neochromosome’s primary industry is Biotechnology.
-
Is Neochromosome a private or public company?
Neochromosome is a Private company.
-
What is Neochromosome’s current revenue?
The current revenue for Neochromosome is .
-
How much funding has Neochromosome raised over time?
Neochromosome has raised $100K.
-
Who are Neochromosome’s investors?
Alexandria LaunchLabs, Endless Frontier Labs, National Institute Of Allergy and Infectious Diseases, and National Institutes of Health have invested in Neochromosome.
-
When was Neochromosome acquired?
Neochromosome was acquired on 01-Jan-2025.
-
Who acquired Neochromosome?
Neochromosome was acquired by OpenTrons.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process